Allspring Global Investments
LFCR icon

Allspring Global Investments’s Lifecore Biomedical LFCR Stock Holding History

Allspring Global Investments’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-64
Closed -$315 – 2119
2024
Q3 		$315 Buy
+64
New +$334 ﹤0.01% 2391
2023
Q1 		– Sell
-7,115
Closed -$46.1K – 2864
2022
Q4 		$46.1K Sell
7,115
-156
-2% -$1.29K ﹤0.01% 2353
2022
Q3 		$64K Buy
7,271
+5,497
+310% +$55.9K ﹤0.01% 2252
2022
Q2 		$17K Sell
1,774
-29,148
-94% -$289K ﹤0.01% 2519
2022
Q1 		$358K Sell
30,922
-39,461
-56% -$439K ﹤0.01% 2372
2021
Q4 		$781K Buy
+70,383
New +$683K ﹤0.01% 2086

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments's LFCR Position: Q4 2024 in Review

Allspring Global Investments sold out of Lifecore Biomedical (LFCR) in Q4 2024, closing a stake of 64 shares — an estimated $315 sold.

Allspring Global Investments first reported a position in LFCR in Q4 2021 and held it in 6 quarters. The position peaked at $781K in Q4 2021. 77 funds tracked by Wall St. Rank hold LFCR as of Q4 2024.

  • Allspring Global Investments reported no remaining Lifecore Biomedical position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 64 Lifecore Biomedical shares in Q4 2024, an estimated $315.
  • Allspring Global Investments first reported a position in Lifecore Biomedical in Q4 2021 and held it in 6 quarters.
  • Allspring Global Investments's Lifecore Biomedical position peaked at $781K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.